0–24 years | 25–44 years | 45–64 years | 65–99 years | |||||
---|---|---|---|---|---|---|---|---|
CPRd, % | ASE SPRa, % (CIc) | CPRd, % | ASE SPRa % (CIc) | CPRd, % | ASE SPRa, % (CIc) | CPRd, % | ASE SPRa, % (CIc) | |
CDMPb MMe2+ | 0.16 | 0.13 (0.12, 0.15) | 5.3 | 5.8 (5.6, 5.9) | 40.6 | 37.8 (37.6, 38.1) | 72.7 | 72.5 (72.0, 72.9) |
CDMPb MMe3+ | 0.02 | 0.01 (0.01, 0.02) | 1.7 | 1.9 (1.8, 2.0) | 21.0 | 19.1 (18.9, 19.3) | 49.9 | 49.7 (49.4, 50.0) |
Fortin MMe2+ | 0.73 | 0.61 (0.58, 0.65) | 8.1 | 8.9 (8.7, 9.0) | 48.2 | 45.3 (45.1, 45.6) | 77.5 | 77.3 (76.9, 77.7) |
Fortin MMe3+ | 0.11 | 0.08 0.07, 0.10) | 3.7 | 4.0 (3.9, 4.1) | 30.9 | 28.5 (28.3, 28.7) | 61.1 | 60.9 (60.5, 61.2) |